Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for therapy using MAO inhibitors].

M Schmauss1, A Erfurth

  • 1Psychiatrische Klinik der Universität München.

Psychiatrische Praxis
|August 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same author

Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study.

Acta psychiatrica Scandinavica·2025
Same author

[ECMO Therapy in a Case of Severe ARDS Related to COVID-19].

Pneumologie (Stuttgart, Germany)·2020
Same author

Implementing shared decision-making on acute psychiatric wards: a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS).

Epidemiology and psychiatric sciences·2020
Same author

[Psychopathological Differentiation of Psychotic Symptoms].

Fortschritte der Neurologie-Psychiatrie·2016
Same author

The connection of temperament with ADHD occurrence and persistence into adulthood - An investigation in 18 year old males.

Journal of affective disorders·2016
Same journal

[Weight-related nutritional interventions for people with mental illness in psychiatric clinics in Germany].

Psychiatrische Praxis·2026
Same journal

[Interdisciplinary Collaboration between Social Service and Case Management in Child and Adolescent Psychiatry: A Qualitative Study of Barriers, Facilitators and the Family Caregiver Perspective].

Psychiatrische Praxis·2026
Same journal

[Work with People with Intellectual Disabilities and Challenging Behavior: Resources, Stressors, and Organizational Approaches].

Psychiatrische Praxis·2026
Same journal

[When IPS Coaching isn't always effective: Findings from the German IPS-ZIB Project].

Psychiatrische Praxis·2026
Same journal

[Borderline personality disorder as a severe mental illness: results of an empirical study].

Psychiatrische Praxis·2026
Same journal

[Firearm Suicides In Switzerland From 1969 To 2023].

Psychiatrische Praxis·2026
See all related articles

Monoamine oxidase inhibitors (MAOIs) are effective for anxiety and depression but are underutilized due to exaggerated fears. With proper precautions, MAOIs offer a valuable treatment option for various psychiatric disorders.

Area of Science:

  • Psychiatry
  • Pharmacology

Context:

  • Monoamine oxidase inhibitors (MAOIs) are a class of psychoactive drugs.
  • These drugs are underutilized due to a historical fear of their side effects and toxicity.
  • MAOIs have demonstrated efficacy across a spectrum of psychiatric conditions.

Purpose:

  • To reassess the utility and safety profile of monoamine oxidase inhibitors (MAOIs).
  • To highlight the therapeutic potential of MAOIs in treating anxiety and depressive disorders.
  • To address and correct common misconceptions regarding MAOI-associated risks.

Summary:

  • MAOIs are effective for anxiety disorders, particularly those with phobic or panic symptoms.
  • They are also beneficial for melancholic depression, especially in outpatients with low energy, bipolar history, or TCA non-response.

Related Experiment Videos

  • Their primary utility lies in treating ambulatory depressives with mixed anxiety-depression symptoms.
  • The risks, including hypertensive crisis, are often exaggerated and manageable through dietary adherence and dose adjustment.
  • Selective and reversible MAOIs may offer an improved safety profile over classical agents.

    • Impact:

    • MAOIs represent a valuable, albeit underutilized, therapeutic option for a range of psychiatric disorders.
    • Understanding their manageable risks can encourage wider clinical adoption.
    • This review aims to re-establish MAOIs as a viable treatment in psychiatric pharmacotherapy.